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Abstract 23 
Dopamine D2 receptors (DRD2) have been strongly implicated in reward processing of 24 
natural stimuli and drugs. By using the Approach-Avoidance Task (AAT), we recently 25 
demonstrated that smokers show an increased approach bias toward smoking-related cues but 26 
not toward naturally-rewarding stimuli. Here we examined the contribution of the DRD2 27 
Taq1B polymorphism to smokers’ and non-smokers’ responsivity toward smoking versus 28 
naturally-rewarding stimuli in the AAT. Smokers carrying the minor B1 allele of the DRD2 29 
Taq1B polymorphism showed reduced approach behavior for food-related pictures compared 30 
to non-smokers with the same allele. In the group of smokers, a higher approach-bias toward 31 
smoking-related compared to food-related pictures was found in carriers of the B1 allele. This 32 
pattern was not evident in smokers homozygous for the B2 allele. Additionally, smokers with 33 
the B1 allele reported fewer attempts to quit smoking relative to smokers homozygous for the 34 
B2 allele. This is the first study demonstrating that behavioral shifts in response to smoking 35 
relative to natural rewards in smokers are mediated by the DRD2 Taq1B polymorphism. Our 36 
results indicate a reduced natural-reward brain reactivity in smokers with a genetically 37 
determined decrease in dopaminergic activity (i.e., reduction of DRD2 availability). It 38 
remains to be determined whether this pattern might be related to a different outcome after 39 
psychological cessation interventions, i.e. AAT modification paradigms, in smokers.   40 
 41 
Keywords: nicotine, smoking, approach-avoidance, dopamine D2 receptor, DRD2 Taq1B 42 
polymorphism  43 
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1. Introduction 44 
According to dual-process models, addictive behaviors occur as a consequence of an 45 
imbalance between a slowly operating reflective instance and a fast, approach-oriented or 46 
impulsive instance [1, 2]. The latter includes automatic approach biases toward drug-related 47 
cues which represent important triggers for both the initiation of drug intake and the “urge” to 48 
continue chronic drug use. In recent years, new paradigms have been developed for both the 49 
assessment and modification of such drug-cue induced automatic approach tendencies in the 50 
context of different addictions. The Approach-Avoidance Task (AAT) [3] has been used to 51 
measure existing approach biases in heroin [4], cannabis [5], alcohol [6] and nicotine 52 
addiction [7]. Likewise, several training versions of the AAT exist, which have been 53 
successfully employed to reduce approach biases toward addictive stimuli and to increase 54 
efficacy of conventional cessation interventions [8, 9] (for a review see: [2]).   55 
We have recently examined approach biases for smoking-related and naturally-56 
rewarding cues in smokers by means of the AAT [10]. We demonstrated that smoking is 57 
associated with a stronger approach bias for smoking-related pictures relative to naturally-58 
rewarding cues, in particular pictures of highly palatable food [10]. Although imaging studies 59 
already suggested a decrease in natural reward responsivity in the course of various 60 
addictions, our findings provide the first behavioral evidence for a shift in responsivity to drug 61 
cues at the expense of naturally-rewarding stimuli in smokers [11, 12]. Research on the 62 
functional significance and the underlying neuronal mechanisms mediating this shift in 63 
reward reactivity in addiction is still limited. However, it has been proposed that adaptations 64 
in meso-corticolimbic dopamine signaling are likely to contribute to a decrease in 65 
motivational and behavioral responses to drugs and natural rewards in the course of an 66 
addiction [13-15]. For instance, a diminished activation of meso-striatal and meso-67 
corticolimbic brain regions in response to natural reinforcers in detoxified cocaine addicts has 68 
been demonstrated [16]. Likewise, monetary rewards which activate typical dopaminergic 69 
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regions including the striatum and the prefrontal cortex in non-smokers are ineffective in 70 
activating the same reward circuits in smokers [17]. 71 
Since chronic drug use is accompanied with a progressive downregulation of 72 
dopamine D2 receptors (DRD2) in the meso-striatal brain regions [19, 20] and since DRD2 73 
have been strongly implicated in the processing of naturally-rewarding stimuli and drugs [21], 74 
a decreased DRD2 density in addicts might account for the diminished responsivity toward 75 
natural rewards as a consequence of chronic substance use [19]. In this instance, it is well 76 
documented that polymorphisms of the DRD2 gene might represent susceptibility factors for 77 
various addictive phenotypes [21, 22]. The B1 allele of DRD2 Taq1B polymorphism in either 78 
heterozygosity or homozygosity is associated with less DRD2 density [23]. Subjects carrying 79 
the B1 allele exhibit an increased vulnerability to smoking [24, 25] and other addictive 80 
behaviors [26, 27] (for a review see: [28]) probably due to alterations in reward sensitivity 81 
[20]. With respect to processes related to smoking cessation in particular, a prominent role of 82 
the DRD2 Taq1B polymorphism has been confirmed [21, 22]. Compared to smokers 83 
homozygous for the B2 allele, smokers with the minor B1 allele show fewer attempts to quit 84 
and stronger withdrawal symptoms after quitting smoking [29, 30], and are younger at the 85 
onset of smoking [24, 25, 31] which is inversely correlated to tobacco dependence [32] and to 86 
more difficulties to quit later in life [33].  87 
Given the important role of dopaminergic neurotransmission in reward processing of 88 
natural stimuli [16] and drugs [19] and the genetic modulation of DRD2 functionality in 89 
tobacco dependence [21, 22], we sought to determine whether the Taq1B polymorphism of 90 
the DRD2 gene affects differences in smokers’ and non-smokers’ approach-avoidance biases 91 
toward smoking versus natural-reward stimuli in the AAT. To this end, we reanalyzed 92 
behavioral and self-report data from our previous study examining approach-avoidance 93 
tendencies in smokers and non-smokers [10]. We expected that depending on the smoking 94 
status, carriers of the B1 allele and homozygous carriers of the B2 allele would show 95 
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differences in responsivity toward smoking-related and natural-reward stimuli in the AAT. 96 
Based on previous findings on the association between DRD2 Taq1B polymorphism and 97 
smoking behavior, a diminished approach-bias for natural rewarding cues in smokers carrying 98 
the B1 allele might be expected. Likewise, our previous finding on a stronger approach bias 99 
for smoking-related pictures relative to naturally-rewarding cues in smokers [10] should be 100 
mediated by the DRD2 Taq1B polymorphism and be more pronounced in smokers carrying 101 
the B1 allele.   102 
 103 
2. Material and Methods 104 
Self-report and behavioral measures obtained from participants in the Machulska et al. 105 
(2015) study were reanalyzed to examine the effect of the Taq1B polymorphism of the DRD2 106 
gene on these measures. All subjects were genotyped at the beginning of the study. The final 107 
sample comprised 90 smokers (mean age = 26.6; 44% female; mean Fagerström Test for 108 
Nicotine Dependence Score [FTND] = 3.4), and 49 non-smokers (mean age = 23.3; 59% 109 
female). Each participant provided written informed consent for the experimental procedure 110 
and the study was approved by the local Ethics Committee of the Ruhr-Universität Bochum. 111 
 112 
2.1 Self-report measures 113 
Each participant completed an extensive set of questionnaires concerning her/his: (i) 114 
Current smoking status, (ii) subjective cigarette craving (ranging from 0 (“not at all”) to 5 115 
(“very high”)), (iii) degree of nicotine dependence (FTND with a score of 0 indicating no or 116 
very weak dependence and a score of 10 indicating very high nicotine dependence [34]; 117 
German version: [35]), (iv) attitude toward smoking (items ranging from -3 and +3; [36]) and 118 
(v) smoking abstinence motivation (Stages of Change Scale [37]; German version: [38]). For 119 
full description of all questionnaires see Machulska and colleagues [10].  120 
 121 
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2.2 Automatic approach and avoidance tendencies 122 
Automatic approach and avoidance tendencies were assessed with an adapted version 123 
of the Nicotine-Approach-Avoidance-Task (N-AAT). For a detailed task description see: [10]. 124 
Briefly, during the AAT, discrete pictures from four different categories were displayed on a 125 
computer screen: (a) smoking-related pictures, (b) shape- and color-matched pictures of tooth-126 
cleaning, (c) pictures of highly palatable food (e.g., pizza, ice cream, etc.) and (d) shape- and 127 
color-matched neutral pictures (i.e., empty dishes). Each picture was either rotated 3° to the 128 
left or 3° to the right. Participants were instructed to pull pictures rotated to the left and to 129 
push pictures rotated to the right, as quickly and accurately as possible by using a joystick 130 
which was connected to the computer. Upon a pull movement, picture size increased, whereas 131 
upon a push movement, picture size decreased, creating a zooming effect [3]. Each picture 132 
from the four picture categories was presented for a total of six times (three times in pull-133 
closer format and three times in push-away format), resulting in 192 trials. 134 
 135 
2.3 Genotyping 136 
All participants were informed to refrain from eating food and drinking beverages 137 
apart from water approximately. 60 minutes prior to the study. DNA samples were collected 138 
using Oragene saliva kits (DNA Genotek, Ottawa, Canada). DNA extraction and genotyping 139 
was performed using established procedures according to the manufacturer’s protocol. The 140 
DRD2 Taq1B polymorphism was genotyped by LGC Genomics (Hoddesdon, UK) using 141 
KASP technology with validated arrays. Five participants (all smokers) could not be 142 
genotyped, giving a total sample of 134 participants and a genotyping success rate of 96.4%.  143 
 144 
2.4 Data preparation and statistical analysis 145 
The Hardy-Weinberg exact test was used [https://www.cog-146 
genomics.org/software/stats] to analyze whether the genotype distribution is in Hardy-147 
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Weinberg equilibrium. Chi-square tests were used for the statistical analysis of allele 148 
frequencies and the distribution of genotypes in smokers and non-smokers. 149 
Genotype was defined using a dominant model: Homozygotes for the minor B1 allele 150 
(B1/B1) were grouped together with heterozygotes (B1/B2) and compared to homozygotes for 151 
the major B2 allele (B2/B2).  152 
Individual AAT bias scores were calculated for each participant. First, error trials were 153 
removed and AAT-bias scores were calculated by subtracting median reaction times (RTs) for 154 
pulling a picture from median RTs for pushing a picture for each of the four picture 155 
categories, separately (median RTpush – median RTpull; see: [10]). 156 
To examine whether the genotype contributed to differences in smokers’ and non-157 
smokers’ AAT bias scores, a 2 (genotype: B1 allele carriers versus B2 homozygotes) x 2 158 
(smoking status: smoker versus non-smoker) x 4 (picture category: nicotine-related versus 159 
tooth-cleaning versus food-related versus neutral pictures) mixed design ANOVA was 160 
conducted. Significant main effects and/or first-order (two-way) interactions were 161 
investigated with simple effect analyses. To investigate the second-order (three-way) 162 
interaction, two separate 2 x 4 ANOVAS were conducted with genotype removed and 163 
smoking status (smoker versus non-smoker) as the main between-subjects factor. To account 164 
for multiple testing, a more conservative level of significance was applied, using the 165 
Bonferroni correction for multiple (n) testing (pcorrected = puncorrected x n). Separate univariate 166 
ANOVAS were used to determine genetic influences on smokers’ smoking history and 167 
behavior, i.e. subjective craving, degree of nicotine dependence, motivation to quit smoking 168 
and attempts to quit smoking during the last 12 months. Again, Bonferroni correction was 169 
used to ensure that the cumulative Type I error was below α = .05.  Analyses were performed 170 
using IBM SPSS Statistics for Windows 23. 171 
 172 
 173 
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 175 
3. Results 176 
3.1 Genotyping 177 
Genotyping resulted in two subjects (both smokers) homozygous for the B1 allele, 39 178 
subjects with the heterozygous B1B2 genotype (26 smokers and 13 non-smokers), and 93 179 
subjects homozygous for the major B2 allele (57 smokers and 36 non-smokers). Allele 180 
frequencies were .15 for the B1 allele (for smokers .18, for non-smokers .13) and .84 for the 181 
B2 allele (for smokers .82, for non-smokers .87), respectively. No significant differences in 182 
allele frequencies were found between smokers and non-smokers (ps > .33). No significant 183 
deviations from Hardy-Weinberg equilibrium were detected (p = 0.52). Sample characteristics 184 
according to smoking status and genotype are summarized in Table 1. 185 
 186 
3.2 Automatic approach and avoidance tendencies 187 
Mean AAT reaction times per genotype and smoking status for pulling versus pushing 188 
a picture are summarized in Table 2. To test the effect of the DRD2 Taq1B polymorphism on 189 
automatic approach-avoidance tendencies assessed with the AAT, a 2 x 2 x 4 mixed design 190 
ANOVA with smoking status (smoker vs. non-smoker) and genotype (B1 allele carriers vs. 191 
B2 homozygotes) as between-subjects factors and picture category (nicotine-related vs. tooth-192 
cleaning vs. food-related vs. neutral pictures) as within-subjects factor was conducted. As 193 
published previously [10], there was a significant main effect of picture category, F(3, 128) = 194 
10.54, p < .001, η² = .2., and a significant picture category x smoking status interaction, F(3, 195 
128) = 5.29, p = .002, η² = .11. Furthermore, a significant picture category x genotype 196 
interaction was evident, F(3, 128) = 5, p = .003, η² = .11. Irrespective of smoking status, 197 
simple effect analyses indicated that B1 allele carriers showed a larger avoidance bias toward 198 
tooth-cleaning pictures (M = -26, SD = 11) as compared to nicotine-related (M = 3, SD = 12; p 199 
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= .05), neutral (M = 21, SD = 11; p < .001), and, by trend, food-related pictures (M = 1, SD = 200 
10; p = .075). Furthermore, B2 homozygotes showed a higher approach bias toward nicotine-201 
related pictures (M = 24, SD = 8) relative to tooth-cleaning (M = -10, SD = 7; p < .001) and 202 
relative to neutral pictures (M = -2, SD = 7; p < .001). In addition, B2 homozygotes showed a 203 
larger approach bias toward food-related pictures (M = 11, SD = 6) relative to tooth-cleaning 204 
pictures (p = .01).  205 
Smoking status differentially affected the effect of genotype on AAT biases for the 206 
different picture categories, as the smoking status x DRD2 genotype x picture category 207 
interaction approached significance (F(3, 128) = 2.63, p = .053, η²  = .06). In order to obtain 208 
an accurate picture of the three-way interaction, we conducted two 2 x 4 ANOVAS for each 209 
genotype separately and with smoking status (smoker versus non-smoker) as the between 210 
subjects factor.  211 
For the B1 allele, Bonferroni corrected analyses revealed a main effect of picture 212 
category, F(3, 37) = 5.84, pcorrected = .004, η² = .32, qualified by a significant smoking status x 213 
picture category interaction, F(3, 37) = 4.95, pcorrected = .01, η² = .29. Specifically, on a 214 
between-group level, simple effect analyses revealed that smokers carrying the B1 allele 215 
showed less approach for food images than non-smokers carrying the B1 allele (Msmokers+B1 =  216 
-16, SD = 9, Mnon-smokers+B1 = 18, SD = 13, p = .03) (see Figure 1). No other between-group 217 
differences reached significance (for smoking pictures: p = .10, for tooth-cleaning pictures: p 218 
= .08, for neutral pictures: p = .62). Furthermore, on a within-group level, genotype affected 219 
approach biases in smokers in particular, evidenced by a decreased approach bias for food 220 
images (Mfood = -16, SD = 9) relative to nicotine-related pictures (Mnicotine = 20, SD = 12; p = 221 
.03) and relative to neutral pictures (Mneutral = 16, SD = 11; p = .02) in smokers carrying the 222 
B1 allele. Furthermore, non-smokers with the B1 allele expressed a stronger avoidance bias 223 
for tooth-cleaning images relative to food images (Mtooth-cleaning = -45, SD = 18; Mfood = 18, SD 224 
= 13, p = .005) and relative to neutral images (Mneutral = 26, SD = 16, p = .002).  225 
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Finally, no group differences in response to the four picture categories occurred for B2 226 
homozygotes as evidenced by a non-significant interaction between smoking status and 227 
picture category (F(3, 89) < 1, pcorrected = .86, η² = .03). 228 
 229 
3.3 Self-report measures 230 
The DRD2 Taq1B polymorphism had no effect on craving or nicotine addiction 231 
severity (FTDN score) in smokers (see Table 1 for statistics; all pscorrected ≥ 0.20; separate one-232 
way ANOVAs with genotype as the between-subjects factor). However, the DRD2 Taq1B 233 
polymorphism had an influence on abstinence motivation in smokers (Stages of change scale; 234 
see Table 1): Smokers homozygous for the B2 allele indicated that they had made twice as 235 
many quit attempts in the last 12 months than smokers with the B1 allele (MB2smokers = 1.9, SD 236 
= 1.4; MB1smokers = 1, SD = 1.3; F(1, 82) = 8.82,  pcorrected = .02, η² = .1). 237 
 238 
4. Discussion 239 
The present study sought to determine the role of the DRD2 Taq1B polymorphism on 240 
approach-avoidance biases toward smoking-related and natural-reward stimuli in smokers and 241 
non-smokers. To this end, we reanalyzed data from our recent study [10] to examine the 242 
contribution of the DRD2 gene on approach-avoidance tendencies in smokers and non-243 
smokers.  244 
While we did not find a genotype-mediated difference in approach-avoidance behavior 245 
in the entire sample, we found genotype x smoking status interactions with respect to specific 246 
approach biases towards smoking-related relative to natural-reward related stimuli. In 247 
particular, smokers carrying the B1 allele showed a reduced approach behavior for natural 248 
rewarding (food) stimuli compared to non-smokers with the same allele. The DRD2 Taq1B 249 
polymorphism, however, did not influence responsivity toward different picture categories in 250 
the AAT in non-smokers. Interestingly, in the group of smokers, a higher responsivity toward 251 
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smoking-related relative to food-related pictures in the AAT was found in carriers of the B1 252 
allele. Such a pattern was not found in smokers homozygous for the B2 allele. This pattern of 253 
findings suggests that the B1 allele in combination with smoking behavior is associated with a 254 
decreased sensitivity to naturally-rewarding stimuli (i.e., pictures of highly palatable food).  255 
Furthermore, as an important addition to previous results [10] that indicated a shift in 256 
approach-bias toward smoking-related stimuli relative to natural-reward stimuli, we found 257 
that this shift was limited to smokers with the B1 allele. Our findings are indicative of a 258 
genetic contribution to individual variability in approach-avoidance behavior towards 259 
naturally-rewarding and smoking-related stimuli in smokers similar to previous findings in 260 
hazardous drinkers [6].   261 
Several previous studies confirmed a close relation between polymorphisms in the 262 
DRD2 gene and tobacco addiction. In this instance, both the B1 allele of the Taq1B 263 
polymorphism of the DRD2 gene and the minor A1 allele of the adjacent ankyrin repeat and 264 
kinase domain containing 1 (ANKK1) gene are found in higher frequency among 265 
polysubstance abusers [39, 40], cocaine-dependent subjects [41, 42] and smokers relative to 266 
non-smokers [24]. A reduced density of dopamine receptors has been reported for both, the 267 
minor A1 allele of the ANKK1 gene and the minor B1 allele of the DRD2 gene [23]. Reduced 268 
DRD2 availability has been linked to the reward deficiency syndrome [43] which is 269 
characterized by an increased likelihood to develop impulsive or addictive behaviors [21], but 270 
also to more difficulties to abstain from addictive behavior. Here we add new data suggesting 271 
that differences in approach-avoidance tendencies might contribute to these previous findings 272 
regarding the relationship between DRD2 availability and nicotine addiction.  273 
Previous imaging studies have already suggested an increased threshold for activation 274 
of reward circuits in response to monetary [17] or food reward in tobacco smokers [18]. Our 275 
results indicate that such altered responsivity to natural rewards can also be detected on the 276 
behavioral level (by means of the AAT) which, however, is related to individual differences 277 
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in DRD2 availability. A reduced sensitivity to food-related pictures was only found in 278 
smokers carrying the B1 allele which is associated with lower DRD2 availability. Similar to 279 
other drugs, chronic tobacco use leads to a dysregulation of dopaminergic neurotransmission 280 
in meso-corticolimbic areas [15]. These include increases in dopamine cellular activity after 281 
acute tobacco consumption, but also a downregulation of dopaminergic activity in response to 282 
natural reinforcers [15]. Neuroimaging studies [44] suggest that the orbitofrontal cortex is a 283 
central structure responsible for an increased salience attribution to drug cues at the expense 284 
of natural rewards in the course of addictions. Interestingly, reductions in DRD2 go along 285 
with decreased metabolism in prefrontal cortical regions [45]. Thus, in smokers a reduction in 286 
DRD2 density in combination with a decreased prefrontal activity might lead to an aberrant 287 
salience attribution toward drug cues versus food cues representing an important 288 
neuroadaptive change in the mesolimbic dopaminergic function [15]. However, our findings 289 
only partially support this conclusion since smokers with the B1 allele did not show a reduced 290 
responsivity (approach tendency) towards smoking-related cues. This might be due to the fact 291 
that we used a sample of moderate smokers with a mean FTND score of 3.4. Since the AAT is 292 
a measure of impulsive tendencies and the prefrontal cortex has been linked to impulse 293 
control [2], a disruption of prefrontal control due to reduced DRD2 availability might lead to 294 
a greater imbalance between executive and impulsive instances in heavy smokers only [1]. 295 
This, in turn could lead to a more pronounced approach-bias toward smoking cues compared 296 
to other cues. Indeed, evidence from animal and human data suggests a strong negative 297 
association between DRD2 availability and control of impulsivity [46]. Future studies 298 
combining AAT and imaging techniques [47] in heavy smokers genotyped for the Taq1B 299 
polymorphism of the DRD2 gene could be helpful to get more insight into the possible 300 
neuronal underpinnings. 301 
A major limitation of the current study is the small sample size which might have 302 
limited the power to detect overall group differences. In particular the smoking status x DRD2 303 
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genotype x picture category approached borderline statistical significance (p=0.053). 304 
According to discriminatory power analyses which we conducted a posteriori, power was 305 
sufficient for detecting main effects and two-way interactions (1-ß > .80), however, the power 306 
to detect a three-way interaction was indeed very small (1-ß = .65). Thus, the current findings 307 
can be considered as promising, but tentative, and in need of replication with a larger sample. 308 
Furthermore, it would be valuable to investigate the contribution of other dopaminergic 309 
pathway genes on complex smoking behavior phenotypes since it is likely that a single-310 
nucleotide polymorphism has only small effects on smoking.  311 
Nevertheless, our results may have implications for the development of more 312 
optimized smoking cessation interventions. For instance, specific training programs based on 313 
the AAT have been successfully employed to change maladaptive approach biases and to 314 
enhance efficacy of psychological cessation interventions in smokers [48, 49]. However, not 315 
all participants profit equally well from these interventions and a large proportion of ex-316 
smokers experience relapse phenomena after successful treatment [30] (see: [50] for a 317 
review). The basic rationale of AAT modification paradigms is to incorporate nicotine-related 318 
cues as a category of stimuli to be avoided while cues corresponding to natural rewards such 319 
as palatable food or pictures of pleasant activities should be approached. Thus, in AAT re-320 
training studies for smokers, participants could be trained to abolish approach behavior 321 
towards nicotine stimuli, but could concomitantly be provided with an alternative behavior, 322 
i.e., approaching naturally-rewarding stimuli, or stimuli which are at least less toxic or 323 
detrimental. Hence, from a theoretical perspective, training to approach naturally-rewarding 324 
stimuli is equally important as training to avoid smoking stimuli. Understanding the 325 
genetic/biological basis of these respective approach biases in smokers (vs. non-smokers) is 326 
therefore of high interest. Based on the findings from the present study, it could be concluded 327 
that AAT training programs which aim to increase tendencies to approach naturally-rewarding 328 
stimuli (as an alternative category to smoking-related stimuli) in smokers would be less 329 
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efficient in B1 allele carriers or that a more extensive retraining protocol would be needed for 330 
those participants. However, it remains to be determined whether this would also be  331 
associated with a less efficient treatment outcome in smokers carrying the B1 allele relative to 332 
those homozygous for the B2 allele. Nevertheless, we found that smokers with the B1 allele 333 
underwent fewer attempts to quit smoking compared to smokers homozygous for the B2 allele 334 
which indeed suggests a more persistent course of smoking behavior. The latter finding 335 
corroborates existing literature showing a negative influence of the B1 allele of the Taq1B 336 
polymorphism on smoking severity and the ability to abstain from smoking [29, 30].  337 
In conclusion, our results indicate a reduced natural-reward brain reactivity in smokers 338 
with the B1 allele of the DRD2 Taq1B polymorphism as evidenced with the AAT. Such a 339 
genetically determined decrease in dopaminergic activity (i.e., reduction of DRD2 340 
availability) might result in a different outcome after psychological cessation interventions in 341 
smokers [48], which however needs to be explored in future research. 342 
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Fig 1 Approach and avoidance tendencies for each of the genotypes: AAT-Bias Scores were 509 
calculated by subtracting median reaction times (RTs) for pulling a picture from median RTs 510 
for pushing a picture. * p < .05. Error bars include 95%-Confidence Intervals (CI). 511 
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Table 1. 522 
Mean sample characteristics and performance in the AAT separated by smoking status and 523 
DRD2 genotype. 524 
 Smokers   Non-smokers  
B1 allele 
carriers 
B2 allele 
homozygotes 
p B1allele 
carriers 
B2 allele 
homozygotes 
p 
N 28 57 -  13 36 - 
Age 25.6 (3.3) 27.2 (7.5) .29  24.6 (3.9) 22.9 (3.2) .12 
Gender 
(%female) 
54 40 .25  62 58 .84 
Smoking 
attitude 
0 (.5) -.2 (.5) .05  -2 (.7) -1.8 (.6) .30 
Craving 2.4 (1.3) 2.6 (1.5) .56  0 0 - 
FTND-Score 3.8 (2.5) 3.1 (2.2) .23  - - - 
Abstinence 
motivation  
.7 (.9) .9 (.8) .36  - - - 
Quit attempts/ 
last year 
1 (1.3) 1.9 (1.4) .005  - - - 
Error rate in  
AAT (%) 
8 (5) 8 (5) .59  8 (3) 12 (6) .01 
Note. N = number of participants; FTND-Score = Score in Fagerström Test for Nicotine 525 
Dependence; scores in abstinence motivation vary between 0 = precontemplation/no intention 526 
to quit smoking in the following 6 months and 4 = maintenance/abstinence from smoking 527 
>6months; standard deviations are given in parentheses. Continuous variables were analyzed 528 
using univariate ANOVAs, categorical variables were analyzed using chi-square-tests. All p-529 
values are two-tailed.530 
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Table 2.  531 
Mean AAT reaction times per genotype and smoking status for each picture category and response type. 532 
 B1 allele carriers  B2 allele homozygotes 
Smokers  Non-smokers Smokers  Non-smokers 
Picture category / Response direction pull push pull push  pull push pull push 
Nicotine-related pictures 596 (114) 616 (114)  635 (123) 620 (118)   621 (135) 649 (124)  573 (103) 593 (85) 
Tooth-cleaning pictures 607 (123) 600 (94)  646 (130) 601 (111)   638 (118) 623 (120)  585 (110) 579 (86) 
Food pictures 610 (120) 594 (93)  624 (118) 642 (123)   626 (118) 630 (111)  573 (88) 592 (74) 
Neutral pictures 590 (107) 606 (97)  606 (106) 632 (133)   642 (138) 635 (124)  579 (78) 582 (86) 
Note. Reaction times are displayed in milliseconds. Standard deviations are given in parentheses.  533 
 534 
 535 
